Leucine/nicotinic acid(NuSirt Biopharma)

N/A

Report date: 2025/12/18 17:47:08

Base Information

Drug NameLeucine/nicotinic acid(NuSirt Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAmino acid replacementsHydroxycarboxylic acid receptor 2 agonistsHM74 nicotinic acid GPCR agonists
TargetsHydroxycarboxylic acid receptor 2HM74 nicotinic acid GPCR
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes LeucineNicotinic Acid
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNusirt Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesNusirt Biopharma
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A